Guyer William Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
10
Insider Sells Sum
$4.55M

Insider Activity of Guyer William

According to the SEC Form 4 filings, Guyer William, being in a position of

  1. Chief Development Officer at Corcept Therapeutics Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 204500 shares for $13.11M,
    over all time since 2023-12-22, has bought 0 shares, and sold 457894 shares for $28.12M.

Biography of Guyer William

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $13,111,76513100

Comparison of Insiders on Amount of Buys and Sells

2026-08-10SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
16,300
0.0154%
$113.43$1.85M+0.02%
2026-08-04SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
3,700
0.0035%
$113.12$418,562+3.83%
2026-07-07SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
20,000
0.0184%
$93.13$1.86M+19.95%
2026-06-02SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
20,000
0.0185%
$70.60$1.41M+55.21%
2026-05-05SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
20,000
0.0188%
$51.83$1.04M+84.64%
2026-04-07SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
20,000
0.0185%
$40.97$819,400+117.56%
2026-03-20SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
11,767
0.0115%
$36.01$423,730+155.43%
2026-03-04SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
8,233
0.0078%
$35.99$296,346+141.75%
2026-02-03SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
20,000
0.0191%
$40.87$817,334+100.86%
2026-01-06SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
20,000
0.0191%
$35.18$703,656+107.13%
2025-12-02SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
20,000
0.0189%
$80.08$1.6M-1.05%
2025-11-25SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
4,500
0.0045%
$80.90$364,070-0.54%
2025-11-05SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
20,000
0.0195%
$75.36$1.51M+3.08%
2025-10-07SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
20,000
0.0189%
$89.94$1.8M-16.91%
2025-09-02SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
20,000
0.0187%
$70.49$1.41M+2.3%
2025-08-08SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
35,007
0.033%
$71.77$2.51M-0.98%
2025-08-05SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
14
<0.0001%
$71.77$1,005+1.53%
2025-07-18SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
500
0.0005%
$73.44$36,721-0.62%
2025-07-17SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
4,379
0.0042%
$73.48$321,774-3.64%
2025-07-01SaleCorcept Therapeutics Incorporated
CORT
Chief Development Officer
100
0.0001%
$73.50$7,351+1.47%
Total: 33
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.